THE RISE OF “PHARMACY DESERTS”: THE IMPACT OF RETAIL DRUGSTORE CLOSURES ON VULNERABLE POPULATIONS AND MEDICATION ACCESSIBILITY

Abstract

The growing phenomenon of “pharmacy deserts” has emerged as a significant public health concern in many countries, particularly within economically disadvantaged and medically underserved communities. Pharmacy deserts refer to geographic regions where residents experience limited or absent access to community pharmacies and essential pharmaceutical services. Recent waves of national retail drugstore closures have intensified healthcare disparities by reducing access to prescription medications, vaccination services, chronic disease management, medication counseling, and preventive healthcare support. Large retail pharmacy chains have increasingly closed outlets due to financial pressures, changing consumer behaviors, competition from online pharmacies, reimbursement challenges, workforce shortages, and evolving healthcare economics. The consequences of pharmacy closures disproportionately affect vulnerable populations including elderly individuals, low-income families, racial and ethnic minorities, rural communities, uninsured populations, and patients with chronic illnesses. Reduced access to nearby pharmacies contributes to medication non-adherence, delayed treatment initiation, worsening chronic disease outcomes, increased emergency department visits, and higher hospitalization rates. Transportation barriers and digital health inequalities further intensify healthcare access limitations among socially disadvantaged populations. Pharmacists continue to play essential roles in addressing medication accessibility challenges through telepharmacy services, mobile pharmacy programs, medication therapy management, patient counseling, vaccination campaigns, and collaborative healthcare initiatives. Technological advancements including mail-order pharmacy systems, digital health platforms, and telemedicine services provide potential solutions to improve pharmaceutical care delivery in underserved regions. Despite emerging innovations, major concerns remain regarding healthcare inequities, regulatory limitations, workforce shortages, reimbursement policies, and sustainability of community pharmacy services. This manuscript explores the causes, epidemiology, social determinants, pharmacist interventions, healthcare consequences, emerging technologies, policy implications, and future strategies associated with the rise of pharmacy deserts and declining medication accessibility among vulnerable populations.